Some thoughts on the reporting of adverse events in phase II cancer clinical trials
- PMID: 16921032
- DOI: 10.1200/JCO.2006.06.9856
Some thoughts on the reporting of adverse events in phase II cancer clinical trials
Comment in
-
More thoughts on the reporting of adverse events in cancer clinical trials.J Clin Oncol. 2007 Mar 1;25(7):918; author reply 918-9. doi: 10.1200/JCO.2006.09.3948. J Clin Oncol. 2007. PMID: 17327621 No abstract available.
Comment on
-
Dealing with a deluge of data: an assessment of adverse event data on North Central Cancer Treatment Group trials.J Clin Oncol. 2005 Dec 20;23(36):9275-81. doi: 10.1200/JCO.2004.00.0588. J Clin Oncol. 2005. PMID: 16361625
-
Adverse event reporting in publications compared with sponsor database for cancer clinical trials.J Clin Oncol. 2006 Aug 20;24(24):3933-8. doi: 10.1200/JCO.2005.05.3959. J Clin Oncol. 2006. PMID: 16921045
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources